Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children

References

• Bhakta NR, Woodruff PG. Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev. 2011;242(1):220–232. doi:10.1111/j.1600-065X.2011.01032.x
   PubMedGoogle Scholar
• Al-Sheyab NA, Alomari MA. Prevalence, associated factors, and control level of asthma symptoms among adolescents in Northern Jordan. Int J Adolesc Med Health. 2018;32(3). doi:10.1515/IJAMH-2017-0159
   PubMedGoogle Scholar
• The Hashemite Kingdom of Jordan The Higher Health Council. The national strategy for health sector in Jordan; 2015.
   Google Scholar
• Abu-Ekteish F, Otoom S, Shehabi I. Prevalence of asthma in Jordan: comparison between bedouins and urban schoolchildren using the international study of Asthma and allergies in childhood Phase III protocol. Allergy Asthma Proc. 2009;30(2):181–185. doi:10.2500/AAP.2009.30.3208
   PubMed Web of Science ®Google Scholar
• Mulholland A, Ainsworth A, Pillarisetti N. Tools in Asthma evaluation and management: when and how to use them? Indian J Pediatr. 2018;85(8):651–657. doi:10.1007/s12098-017-2462-6
   PubMed Web of Science ®Google Scholar
• Wan XC, Woodruff PG. Biomarkers in Severe Asthma. Immunol Allergy Clin North Am. 2016;36(3):547. doi:10.1016/J.IAC.2016.03.004
   PubMed Web of Science ®Google Scholar
• Darbà J, Ascanio M, Syk J, Alving K. Economic evaluation of the use of FeNO for the diagnosis and management of Asthma patients in primary care in Sweden. Clin Outcomes Res. 2021;13:289–297. doi:10.2147/CEOR.S306389
   PubMed Web of Science ®Google Scholar
• Mehta S, Lilly CM, Rollenhagen JE, Haley KJ, Asano K, Drazen JM. Acute and chronic effects of allergic airway inflammation on pulmonary nitric oxide production. Am J Physiol Lung Cell Mol Physiol. 1997;272(1):16. doi:10.1152/AJPLUNG.1997.272.1.L124
   Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615. doi:10.1164/RCCM.9120-11ST
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease: GBD cause and risk summaries. Available from: https://www.thelancet.com/gbd/summaries. Accessed August 17, 2022.
   Google Scholar
• World Health Organization. Asthma. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma. Accessed August 17, 2022.
   Google Scholar
• Albataineh E, Al-Zayadneh E, Al-Shagahin H, Soloman A, Altarawneh A, Aldmour I. Asthma control and its predictive factors in adult Asthma Patients. Orig Artic J Clin Med Res. 2019;11(12):807–817. doi:10.14740/jocmr4021
   PubMedGoogle Scholar
• Sachs-Olsen C, Lødrup Carlsen KC, Mowinckel P, et al. Diagnostic value of exhaled nitric oxide in childhood asthma and allergy. Pediatr Allergy Immunol. 2010;21(1–Part–II):e213–e221. doi:10.1111/J.1399-3038.2009.00965.X
   PubMed Web of Science ®Google Scholar
• Karrasch S, Linde K, Rücker G, et al. Accuracy of FENO; for diagnosing asthma: a systematic review. Thorax. 2017;72(2):109 LP–116 . doi:10.1136/thoraxjnl-2016-208704
   Web of Science ®Google Scholar
• Milutinovic PS, Alcorn JF, Englert JM, Crum LT, Oury TD. The receptor for advanced glycation end products is a central mediator of Asthma pathogenesis. Am J Pathol. 2012;181(4):1215–1225. doi:10.1016/J.AJPATH.2012.06.031
   PubMed Web of Science ®Google Scholar
• Sukkar MB, Ullah MA, Gan WJ, et al. RAGE: a new frontier in chronic airways disease. Br J Pharmacol. 2012;167(6):1161–1176. doi:10.1111/J.1476-5381.2012.01984.X
   PubMed Web of Science ®Google Scholar
• Perkins TN, Donnell ML, Oury TD. The axis of the receptor for advanced glycation endproducts in asthma and allergic airway disease. Allergy. 2021;76(5):1350–1366. doi:10.1111/ALL.14600
   PubMed Web of Science ®Google Scholar
• Lyu Y, Zhao H, Ye Y, et al. Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants. Mol Med Rep. 2018;17(3):4131–4137. doi:10.3892/MMR.2017.8302/HTML
   PubMed Web of Science ®Google Scholar
• Sukkar MB, Wood LG, Tooze M, et al. Soluble RAGE is deficient in neutrophilic asthma and COPD. Eur Respir J. 2012;39(3):721–729. doi:10.1183/09031936.00022011
   PubMed Web of Science ®Google Scholar
• Zhang F, Su X, Huang G, et al. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells. Sci Rep. 2017;7(1):1–12. doi:10.1038/s41598-017-14667-4
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jiang Y, Wang W, et al. HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage. Hum Immunol. 2012;73(11):1171–1174. doi:10.1016/j.humimm.2012.08.016
   PubMed Web of Science ®Google Scholar
• Raucci A, Cugusi S, Antonelli A, et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008;22(10):3716–3727. doi:10.1096/FJ.08-109033
   PubMed Web of Science ®Google Scholar
• Hudson BI, Carter AM, Harja E, et al. Identification, classification, and expression of RAGE gene splice variants. FASEB J. 2008;22(5):1572–1580. doi:10.1096/FJ.07-9909COM
   PubMed Web of Science ®Google Scholar
• Li Y, Wu R, Tian Y, Bao T, Tian Z; Allergy ZTAPJ of, 2017 undefined. Fraction of exhaled nitric oxide and soluble receptors for advanced glycation end products are negatively correlated in children with recurrent wheezing. Asian Pac J Allergy Immunol. 2017;35(1):33–37. doi:10.12932/AP0746
   PubMed Web of Science ®Google Scholar
• Patregnani JT, Fujiogi M, Camargo CA, et al. Serum soluble receptor for advanced glycation end products in infants with bronchiolitis: associations with acute severity and recurrent wheeze. Clin Infect Dis an off Publ Infect Dis Soc Am. 2021;73(9):e2665–e2672. doi:10.1093/cid/ciaa1700
   PubMed Web of Science ®Google Scholar
• Liang Y, Hou C, Kong J, et al. HMGB1 binding to receptor for advanced glycation end products enhances inflammatory responses of human bronchial epithelial cells by activating p38 MAPK and ERK1/2. Mol Cell Biochem. 2015;405(1–2):63–71. doi:10.1007/s11010-015-2396-0
   PubMed Web of Science ®Google Scholar
• Exhaled NO. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930. doi:10.1164/RCCM.200406-710ST
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008
   PubMed Web of Science ®Google Scholar
• Liu AH, Zeiger RS, Sorkness CA, et al. The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. J Allergy Clin Immunol. 2010;126(2):267–273, 273.e1. doi:10.1016/j.jaci.2010.05.031
   PubMed Web of Science ®Google Scholar
• Dabbaghzadeh A, Tavakol M, Gharagozlou M. The Role of FENO in comparison to spirometry and ACT in control of children Asthma symptoms. Iran J Allergy Asthma Immunol. 2019;18(5):479–486. doi:10.18502/IJAAI.V18I5.1898
   PubMed Web of Science ®Google Scholar
• Waibel V, Ulmer H, Horak E. Assessing asthma control: symptom scores, GINA levels of asthma control, lung function, and exhaled nitric oxide. Pediatr Pulmonol. 2012;47(2):113–118. doi:10.1002/PPUL.21529
   PubMed Web of Science ®Google Scholar
• Green RJ, Klein M, Becker P, et al. Disagreement among common measures of asthma control in children. Chest. 2013;143(1):117–122. doi:10.1378/chest.12-1070
   PubMed Web of Science ®Google Scholar
• Cabral ALB, Vollmer WM, Barbirotto RM, Martins MA. Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study. Ann Allergy Asthma Immunol. 2009;103(3):206–211. doi:10.1016/S1081-1206(10)60183-4
   PubMed Web of Science ®Google Scholar
• Vijverberg SJH, Koster ES, Koenderman L, et al. Exhaled NO is a poor marker of asthma control in children with a reported use of asthma medication: a pharmacy-based study. Pediatr Allergy Immunol. 2012;23(6):529–536. doi:10.1111/J.1399-3038.2012.01279.X
   PubMed Web of Science ®Google Scholar
• Knuffman J, Sorkness C, Lemanske RF; RLJJ of allergy and, 2009 undefined. Phenotypic predictors of long-term response to inhaled corticosteroid and leukotriene modifier therapies in pediatric asthma. J Allergy Clin Immunol. 2009;123(2):411–416. doi:10.1016/j.jaci.2008.11.016
   PubMed Web of Science ®Google Scholar
• Cano-Garcinuño A, Carvajal-Urueña I, Díaz-Vázquez CA, et al. 5 Clinical correlates and determinants of airway inflammation in pediatric Asthma. Jiaci.org. 2010;20(4):303–310.
   Google Scholar
• Fritsch M, Uxa S, Horak F, et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol. 2006;41(9):855–862. doi:10.1002/PPUL.20455
   PubMed Web of Science ®Google Scholar
• Di Cicco M, Peroni DG, Ragazzo V, Comberiati P. Application of exhaled nitric oxide (FeNO) in pediatric asthma. Curr Opin Allergy Clin Immunol. 2021;21(2):151–158. doi:10.1097/ACI.0000000000000726
   PubMed Web of Science ®Google Scholar
• Wang X, Tan X, Li Q. Effectiveness of fractional exhaled nitric oxide for asthma management in children: a systematic review and meta-analysis. Pediatr Pulmonol. 2020;55(8):1936–1945. doi:10.1002/PPUL.24898
   PubMed Web of Science ®Google Scholar
• Majid H, Kao C. Utility of exhaled nitric oxide in the diagnosis and management of asthma. Curr Opin Pulm Med. 2010;16(1):42–47. doi:10.1097/MCP.0b013e328332ca46
   PubMed Web of Science ®Google Scholar
• Nguyen VN, Chavannes NH. Correlation between fractional exhaled nitric oxide and Asthma Control Test score and spirometry parameters in on-treatment- asthmatics in Ho Chi Minh City. J Thorac Dis. 2020;12(5):2197–2209. doi:10.21037/JTD.2020.04.01
   PubMed Web of Science ®Google Scholar
• Covar RA, Szefler SJ, Martin RJ, et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr. 2003;142(5):469–475. doi:10.1067/mpd.2003.187
   PubMed Web of Science ®Google Scholar
• Taylor DR, Pijnenburg MW, Smith AD, Jongste JCD. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006;61(9):817 LP–827 . doi:10.1136/thx.2005.056093
   Web of Science ®Google Scholar
• Pijnenburg MWH, De Jongste JC. Exhaled nitric oxide in childhood asthma: a review. Clin Exp Allergy. 2008;38(2):246–259. doi:10.1111/J.1365-2222.2007.02897.X
   PubMed Web of Science ®Google Scholar
• Payne DNR, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2012;164(8 I):1376–1381. doi:10.1164/AJRCCM.164.8.2101145
   Google Scholar
• Ferrante G, Malizia V, Antona R, Corsello G, La Grutta S. The value of FeNO measurement in childhood asthma: uncertainties and perspectives. Multidiscip Respir Med. 2013;8(1):50. doi:10.1186/2049-6958-8-50
   PubMedGoogle Scholar
• El-Seify MYH, Fouda EM, Nabih ES. Serum level of soluble receptor for advanced glycation end products in asthmatic children and its correlation to severity and pulmonary functions. Clin Lab. 2014;60(6):957–962. doi:10.7754/CLIN.LAB.2013.130418
   PubMed Web of Science ®Google Scholar
• Tereshchenko S, Smolnikova M, Belenjuk V, Novitsky I. Soluble receptor for advanced glycation end products (sRAGE) in asthmatic children as a new marker of the disease control. Eur Respir J. 2021;58(suppl 65):A3076. doi:10.1183/13993003.CONGRESS-2021.PA3076
   Google Scholar
• Bui H, Keshawarz A, Hwang SJ, et al. A genomic approach identifies sRAGE as a putatively causal protein for asthma. J Allergy Clin Immunol. 2022;149(6):1992–1997.e12. doi:10.1016/j.jaci.2021.11.027
   PubMed Web of Science ®Google Scholar
• Perkins TN, Oczypok EA, Milutinovic PS, Dutz RE, Oury TD. RAGE-dependent VCAM-1 expression in the lung endothelium mediates IL-33-induced allergic airway inflammation. Allergy Eur J Allergy Clin Immunol. 2019;74(1):89–99. doi:10.1111/ALL.13500
   Google Scholar
• Ullah MA, Loh Z, Gan WJ, et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol. 2014;134(2):440–450. doi:10.1016/j.jaci.2013.12.1035
   PubMed Web of Science ®Google Scholar
• Magnier J, Julian V, Sapin V, et al. Soluble Receptor of Advanced Glycation End-Products (sRAGE) in pediatric asthma: a prospective study in 68 children aged 7 years. Appl Sci. 2022;12(12):5926. doi:10.3390/APP12125926
   Google Scholar
• Koyama H, Shoji T, Yokoyama H, et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25(12):2587–2593. doi:10.1161/01.ATV.0000190660.32863.CD
   PubMed Web of Science ®Google Scholar
• Watanabe T, Asai K, Fujimoto H, Tanaka H, Kanazawa H, Hirata K. Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med. 2011;105(4):519–525. doi:10.1016/j.rmed.2010.10.016
   PubMed Web of Science ®Google Scholar